Defibrillator Market

Defibrillator Market Size by Product (External Defibrillators (ED), Implantable Cardioverter Defibrillators (ICD)), End-use (Pre-Hospital, Alternate Care Market, Hospital, Home Healthcare, Public Access Market), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13268
  • Published Date: Jan, 2023
  • Pages: 236
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global defibrillator market was valued at USD 13.69 billion in 2022 and growing at a CAGR of 8.47% from 2023 to 2032. The market is expected to reach USD 30.88 billion by 2032. Asia Pacific is expected to increase the fastest during the forecast period.

Market Introduction:

Defibrillators are medical devices that shock or pulse the heart with electricity to restore regular heartbeat. They prevent or treat an irregular, too slow, or too-fast heartbeat known as an arrhythmia. Defibrillators can also restart a heart that has unexpectedly stopped beating. Defibrillators come in a variety of designs and operate differently. People with a cardiac arrest can be saved using automated external defibrillators (AEDs), which are currently widespread in public places. People who are not trained can use these tools in an emergency. Other defibrillators can stop sudden death when a person is at a high risk of developing a life-threatening arrhythmia. Wearable cardioverter defibrillators (WCDs), worn on the body, and implanted cardioverter defibrillators (ICDs), inserted into the body surgically, are two examples. It can take some time and effort to become accustomed to having a defibrillator in the home, and it's crucial to be aware of any potential problems. A defibrillator gives a heart a restorative shock in fatal situations such as ventricular fibrillation, pulseless ventricular tachycardia, and cardiac arrhythmia. The muscles of the heart are depolarized, and their typical electrical impulse is restored during defibrillation. External defibrillators utilize electrode pads or paddles to identify and treat irregular heartbeats during cardiac arrest. The idea behind defibrillators is the delivery of an electrical shock to the patient's chest. The heart membrane receives impulses. As a result, stabilizes the rhythm of the heartbeat. In emergency medical services, defibrillators are regarded as an efficient resuscitation tool.

Defibrillator Market Size

Get an overview of this study by requesting a free sample

Recent Development

For instance, in August 2019, ZOLL Medical Corporation purchased Cardiac Science Corporation, one of the nation's top AED producers. As a result, ZOLL's line of AED products was expanded, and the company's intentions to expand its AED business internationally were accelerated. 

On the other hand, Abbott received CE Mark for its Gallant CRT-D and ICD products in February 2020.

Physio-control International, a producer of defibrillators and vital sign monitors, was purchased by Stryker Corporation in February 2016 for US$1.28 billion.

Geneva Healthcare, a provider of remote monitoring for implantable cardiac devices, was purchased by BioTelemetry, Inc. in January 2019 for US$45 billion. BioTelemetry is a remote and wireless corporation with a focus on health information.

The Philips pre-hospital wireless monitoring solution for an emergency medical response was introduced in the United States in July 2020. The solution is an all-encompassing system that combines cutting-edge hardware and software to broaden the pre-hospital spectrum of treatment for first responders.

Market Dynamics:

Drivers

The aging population, public AEDs, and rising incidence of cardiac issues - It is anticipated that the market's rise would be driven by the rising frequency of cardiac problems across age groups owing to demands at work, sedentary lifestyles, smoking, drinking, and drug addiction. Atrial fibrillation is becoming more prevalent everywhere. The frequency of people with atrial fibrillation is anticipated to increase. During the projected period, an increasing burden of arrhythmias can boost the market growth. Another market driver is an aging population. Chronic illnesses like cardiovascular diseases are more likely to affect older people. The market is expanding due to rising public AED (automated external defibrillator) usage. As more people become aware of its capability to save lives, many schools, train stations, universities, malls, airports, and recreational infrastructure are deploying the equipment. Anyone can use a defibrillator located in a public area in case of an urgent medical situation. Several nations have installed PADs in public areas as incidents increase.

Opportunities:

Advancements in next-generation defibrillators - The market for defibrillators is projected to grow more quickly than anticipated due to improvements in next-generation defibrillators. Market defibrillators help identify and resolve device-related problems. SCA is the most common reason for death worldwide and is potentially fatal. This condition is manageable with early attention and defibrillation. AEDs are the most popular external defibrillators on the market, and they are predicted to expand at the highest rate in the coming years due to the rising number of heart failure patients using them. The demand increased along with the availability of more AEDs. Wearables are currently ahead of manual external defibrillators. The market growth might be boosted in the coming years by S-ICDs, MRI-compatible ICDs, and CRT-Ds.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the highest in the global defibrillator market, with a share of 37.88% and valued at USD 5.18 billion in 2022. The expansion of the North American market can be linked to initiatives taken by significant businesses, favorable legislation, and highly developed medical facilities in the United States and Canada. For instance, Boston Scientific stated that by the end of 2020, it had deployed about 33,000 Autogen, Incepta, Resonate, Cognis, and Dynagen devices from its CRT-Ds line globally. A strong adoption rate can be seen in the fact that 16,500 of these were registered in the U.S. alone.

North America Region Defibrillator Market Share in 2022 - 37.88%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Product Segment Analysis

The product segment is divided into External Defibrillators (ED) and Implantable Cardioverter Defibrillators (ICD). The Implantable Cardioverter Defibrillators (ICD) segment had the highest market share of 59.03% and was valued at USD 8.08 billion in 2022 in the defibrillator market. The large elderly population in growing economies, the growing product innovations by leading players, and the growing use of this equipment due to the significant occurrence of cardiovascular disorders are the main drivers influencing this market segment. In 2020, Medtronic, for instance, reported sustained adoption and growth of its Claria CRT-D MRI-compatible devices. Along with this, the Crome & Cobalt portfolio of ICDs and CRT-Ds saw significant expansion.

End-use Segment Analysis

The end-use segment is divided into pre-hospital, alternate care market, hospital, home healthcare, and public access market. The hospital segment had the highest market share of 25.78% and was valued at USD 3.52 billion in 2022 in the defibrillator market. This results from a higher-than-usual frequency of cardiac patients receiving care in hospitals and procedures carried out in healthcare facilities. Hospitals use ICDs and external defibrillators more frequently to treat patients who have suffered sudden cardiac arrest and for other purposes. As of January 2021, Boston Scientific, for instance, reported that approximately 659,000 ICDs had been distributed worldwide. Compared to the 600,000 ICDs issued by January 2020, this figure significantly increased by 59,000, demonstrating a high demand.

Some of the Key Market Players:
  • Abbott
  • BIOTRONIK SE & Co. KG
  • Koninklijke Philips N.V.
  • ZOLL Medical Corporation (Asahi Kasei)
  • Progetti Srl
  • MS Westfalia GmbH
  • AXION Ltd.
  • MicroPort Scientific Corporation
  • CU Medical Systems
  • Mediana Co. Ltd.
  • Metrax GmbH – PRIMEDIC
  • Avive Solutions Inc.
  • HeartHero Inc.
  • Medtronic
  • Schiller AG
  • Bexen Cardio
  • METsis Medikal
  • BPL Medical Technologies
  • Jeevtronics Pvt. Ltd.
  • Shenzhen Comen Medical Instruments Ltd.
  • Boston Scientific Corporation
  • Nihon Kohden Corporation
  • Element Science Inc.
  • AMI Italia
  • Stryker
  • Mindray Medical International Ltd.

Report Description: 

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2023 USD 13.69 Billion
Market size value in 2032 USD 30.88 Billion
CAGR (2023 to 2032) 8.47%
Historical data 2020-2021
Base Year 2022
Forecast 2023-2032
Regional Segments The regions analyzed for the market are Europe, Asia Pacific, North America, South America, and Middle East & Africa.
Segments Product, End-use

Frequesntly Asked Questions

As per The Brainy Insights, the size of the defibrillator market was valued at USD 13.69 billion in 2022 & USD 30.88 billion by 2032.

Global defibrillator market is growing at a CAGR of 8.47% during the forecast period 2023-2032.

North America region emerged as the largest market for the defibrillator.

Advancements in next-generation defibrillators is one of the opportunities for the growth of the market.

The market's growth will be influenced by ageing population, public AEDs, and rising incidence of cardiac issues.

1. Introduction
    1.1. Objective of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Product
          4.3.2. Market Attractiveness Analysis By End-use
          4.3.3. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Ageing population, public AEDs, and rising incidence of cardiac issues
    5.3. Opportunities
          5.3.1. Advancements in next-generation defibrillators

6. Global Defibrillator Market Analysis and Forecast, By Product
    6.1. Segment Overview
    6.2. External Defibrillators (ED)
    6.3. Implantable Cardioverter Defibrillators (ICD)

7. Global Defibrillator Market Analysis and Forecast, By End-use
    7.1. Segment Overview
    7.2. Pre-Hospital
    7.3. Alternate Care Market
    7.4. Hospital
    7.5. Home Healthcare
    7.6. Public Access Market

8. Global Defibrillator Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa

9. Global Defibrillator Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in the Defibrillator Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Product Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
    10.1. Abbott
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Product Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. BIOTRONIK SE & Co. KG
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Product Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. Koninklijke Philips N.V.
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Product Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. ZOLL Medical Corporation (Asahi Kasei)
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Product Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. Progetti Srl
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Product Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. MS Westfalia GmbH
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Product Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. AXION Ltd.
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Product Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. MicroPort Scientific Corporation
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Product Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. CU Medical Systems
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Product Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. Mediana Co. Ltd.
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Product Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis
    10.11. Metrax GmbH – PRIMEDIC
          10.11.1. Business Overview
          10.11.2. Company Snapshot
          10.11.3. Company Market Share Analysis
          10.11.4. Company Product Portfolio
          10.11.5. Recent Developments
          10.11.6. SWOT Analysis
    10.12. Avive Solutions Inc.
          10.12.1. Business Overview
          10.12.2. Company Snapshot
          10.12.3. Company Market Share Analysis
          10.12.4. Company Product Portfolio
          10.12.5. Recent Developments
          10.12.6. SWOT Analysis
    10.13. HeartHero Inc.
          10.13.1. Business Overview
          10.13.2. Company Snapshot
          10.13.3. Company Market Share Analysis
          10.13.4. Company Product Portfolio
          10.13.5. Recent Developments
          10.13.6. SWOT Analysis
    10.14. Medtronic
          10.14.1. Business Overview
          10.14.2. Company Snapshot
          10.14.3. Company Market Share Analysis
          10.14.4. Company Product Portfolio
          10.14.5. Recent Developments
          10.14.6. SWOT Analysis
    10.15. Schiller AG
          10.15.1. Business Overview
          10.15.2. Company Snapshot
          10.15.3. Company Market Share Analysis
          10.15.4. Company Product Portfolio
          10.15.5. Recent Developments
          10.15.6. SWOT Analysis
    10.16. Bexen Cardio
          10.16.1. Business Overview
          10.16.2. Company Snapshot
          10.16.3. Company Market Share Analysis
          10.16.4. Company Product Portfolio
          10.16.5. Recent Developments
          10.16.6. SWOT Analysis
    10.17. METsis Medikal
          10.17.1. Business Overview
          10.17.2. Company Snapshot
          10.17.3. Company Market Share Analysis
          10.17.4. Company Product Portfolio
          10.17.5. Recent Developments
          10.17.6. SWOT Analysis
    10.18. BPL Medical Technologies
          10.18.1. Business Overview
          10.18.2. Company Snapshot
          10.18.3. Company Market Share Analysis
          10.18.4. Company Product Portfolio
          10.18.5. Recent Developments
          10.18.6. SWOT Analysis
    10.19. Jeevtronics Pvt. Ltd.
          10.19.1. Business Overview
          10.19.2. Company Snapshot
          10.19.3. Company Market Share Analysis
          10.19.4. Company Product Portfolio
          10.19.5. Recent Developments
          10.19.6. SWOT Analysis
    10.20. Shenzhen Comen Medical Instruments Ltd.
          10.20.1. Business Overview
          10.20.2. Company Snapshot
          10.20.3. Company Market Share Analysis
          10.20.4. Company Product Portfolio
          10.20.5. Recent Developments
          10.20.6. SWOT Analysis
    10.21. Boston Scientific Corporation
          10.21.1. Business Overview
          10.21.2. Company Snapshot
          10.21.3. Company Market Share Analysis
          10.21.4. Company Product Portfolio
          10.21.5. Recent Developments
          10.21.6. SWOT Analysis
    10.22. Nihon Kohden Corporation
          10.22.1. Business Overview
          10.22.2. Company Snapshot
          10.22.3. Company Market Share Analysis
          10.22.4. Company Product Portfolio
          10.22.5. Recent Developments
          10.22.6. SWOT Analysis
    10.23. Element Science Inc.
          10.23.1. Business Overview
          10.23.2. Company Snapshot
          10.23.3. Company Market Share Analysis
          10.23.4. Company Product Portfolio
          10.23.5. Recent Developments
          10.23.6. SWOT Analysis
    10.24. AMI Italia
          10.24.1. Business Overview
          10.24.2. Company Snapshot
          10.24.3. Company Market Share Analysis
          10.24.4. Company Product Portfolio
          10.24.5. Recent Developments
          10.24.6. SWOT Analysis
    10.25. Stryker
          10.25.1. Business Overview
          10.25.2. Company Snapshot
          10.25.3. Company Market Share Analysis
          10.25.4. Company Product Portfolio
          10.25.5. Recent Developments
          10.25.6. SWOT Analysis
    10.26. Mindray Medical International Ltd.
          10.26.1. Business Overview
          10.26.2. Company Snapshot
          10.26.3. Company Market Share Analysis
          10.26.4. Company Product Portfolio
          10.26.5. Recent Developments
          10.26.6. SWOT Analysis

List of Table

1. Global Defibrillator Market, By Product, 2019-2032 (USD Billion) 

2. Global External Defibrillators (ED), Defibrillator Market, By Region, 2019-2032 (USD Billion) 

3. Global Implantable Cardioverter Defibrillators (ICD), Defibrillator Market, By Region, 2019-2032 (USD Billion)

4. Global Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

5. Global Pre-Hospital, Defibrillator Market, By Region, 2019-2032 (USD Billion) 

6. Global Alternate Care Market, Defibrillator Market, By Region, 2019-2032 (USD Billion)

7. Global Hospital, Defibrillator Market, By Region, 2019-2032 (USD Billion)

8. Global Home Healthcare, Defibrillator Market, By Region, 2019-2032 (USD Billion)

9. Global Public Access Market, Defibrillator Market, By Region, 2019-2032 (USD Billion)

10. Global Defibrillator Market, By Region, 2019-2032 (USD Billion) 

11. North America Defibrillator Market, By Product, 2019-2032 (USD Billion) 

12. North America Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

13. U.S. Defibrillator Market, By Product, 2019-2032 (USD Billion) 

14. U.S. Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

15. Canada Defibrillator Market, By Product, 2019-2032 (USD Billion) 

16. Canada Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

17. Mexico Defibrillator Market, By Product, 2019-2032 (USD Billion) 

18. Mexico Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

19. Europe Defibrillator Market, By Product, 2019-2032 (USD Billion) 

20. Europe Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

21. Germany Defibrillator Market, By Product, 2019-2032 (USD Billion) 

22. Germany Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

23. France Defibrillator Market, By Product, 2019-2032 (USD Billion) 

24. France Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

25. U.K. Defibrillator Market, By Product, 2019-2032 (USD Billion) 

26. U.K. Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

27. Italy Defibrillator Market, By Product, 2019-2032 (USD Billion) 

28. Italy Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

29. Spain Defibrillator Market, By Product, 2019-2032 (USD Billion) 

30. Spain Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

31. Asia Pacific Defibrillator Market, By Product, 2019-2032 (USD Billion) 

32. Asia Pacific Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

33. Japan Defibrillator Market, By Product, 2019-2032 (USD Billion) 

34. Japan Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

35. China Defibrillator Market, By Product, 2019-2032 (USD Billion) 

36. China Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

37. India Defibrillator Market, By Product, 2019-2032 (USD Billion) 

38. India Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

39. South America Defibrillator Market, By Product, 2019-2032 (USD Billion) 

40. South America Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

41. Brazil Defibrillator Market, By Product, 2019-2032 (USD Billion) 

42. Brazil Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

43. Middle East and Africa Defibrillator Market, By Product, 2019-2032 (USD Billion) 

44. Middle East and Africa Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

45. UAE Defibrillator Market, By Product, 2019-2032 (USD Billion) 

46. UAE Defibrillator Market, By End-use, 2019-2032 (USD Billion) 

47. South Africa Defibrillator Market, By Product, 2019-2032 (USD Billion) 

48. South Africa Defibrillator Market, By End-use, 2019-2032 (USD Billion)

List of Figures 

1. Global Defibrillator Market Segmentation

2. Defibrillator Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Defibrillator Market Attractiveness Analysis By Product

9. Global Defibrillator Market Attractiveness Analysis By End-use

10. Global Defibrillator Market Attractiveness Analysis By Region

11. Global Defibrillator Market: Dynamics

12. Global Defibrillator Market Share by Product (2023 & 2032)

13. Global Defibrillator Market Share by End-use (2023 & 2032)

14. Global Defibrillator Market Share by Regions (2023 & 2032)

15. Global Defibrillator Market Share by Company (2022)

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global defibrillator market based on below mentioned segments:

Global Defibrillator Market by Product:

  • External Defibrillators (ED)
  • Implantable Cardioverter Defibrillators (ICD)

Global Defibrillator Market by End-use:

  • Pre-Hospital
  • Alternate Care Market
  • Hospital
  • Home Healthcare
  • Public Access Market

Global Defibrillator Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date